Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Feasibility of uterine preservation in the management of early-stage uterine adenosarcomas: a single institute experience.

Lee YJ, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH.

World J Surg Oncol. 2017 Apr 19;15(1):87. doi: 10.1186/s12957-017-1137-0.

2.

Cluster of uterine mullerian adenosarcoma in the Washington, DC metropolitan area with high incidence of sarcomatous overgrowth.

Seidman JD, Wasserman CS, Aye LM, MacKoul PJ, O'Leary TJ.

Am J Surg Pathol. 1999 Jul;23(7):809-14.

PMID:
10403304
3.

Nerve-sparing radical abdominal trachelectomy versus nerve-sparing radical hysterectomy in early-stage (FIGO IA2-IB) cervical cancer: a comparative study on feasibility and outcome.

van Gent MD, van den Haak LW, Gaarenstroom KN, Peters AA, van Poelgeest MI, Trimbos JB, de Kroon CD.

Int J Gynecol Cancer. 2014 May;24(4):735-43. doi: 10.1097/IGC.0000000000000114.

PMID:
24651626
4.

Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.

Krivak TC, Seidman JD, McBroom JW, MacKoul PJ, Aye LM, Rose GS.

Gynecol Oncol. 2001 Oct;83(1):89-94.

PMID:
11585418
5.

Uterine adenosarcomas: A dual-institution experience.

Özgü E, Narin MA, Yalçın HR, Taşçı T, Güngör T, Çavuşoğlu D, Meydanlı MM, Tulunay G.

J Obstet Gynaecol. 2017 Jan;37(1):93-96. doi: 10.1080/01443615.2016.1228619. Epub 2016 Dec 6.

PMID:
27923317
6.

Primary vaginal adenosarcoma with sarcomatous overgrowth.

Toyoshima M, Akahira J, Moriya T, Hayakawa S, Yaegashi N.

Gynecol Oncol. 2004 Dec;95(3):759-61.

PMID:
15582000
7.

Uterine Adenosarcoma with Sarcomatous Overgrowth: A Case Report of Aggressive Disease in a 16-Year-Old Girl and a Literature Review.

Liu H, Shen Z, Wu D, Zhou Y.

J Pediatr Adolesc Gynecol. 2018 Aug;31(4):426-431. doi: 10.1016/j.jpag.2017.12.012. Epub 2018 Jan 6. Review.

PMID:
29317258
8.

Management of uterine adenosarcomas with and without sarcomatous overgrowth.

Tanner EJ, Toussaint T, Leitao MM Jr, Hensley ML, Soslow RA, Gardner GJ, Jewell EL.

Gynecol Oncol. 2013 Apr;129(1):140-4. doi: 10.1016/j.ygyno.2012.12.036. Epub 2012 Dec 30.

PMID:
23283300
9.

Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.

Gallardo A, Prat J.

Am J Surg Pathol. 2009 Feb;33(2):278-88. doi: 10.1097/PAS.0b013e318181a80d.

PMID:
18941402
10.

Uterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrence.

Carroll A, Ramirez PT, Westin SN, Soliman PT, Munsell MF, Nick AM, Schmeler KM, Klopp AH, Fleming ND.

Gynecol Oncol. 2014 Dec;135(3):455-61. doi: 10.1016/j.ygyno.2014.10.022. Epub 2014 Oct 28.

11.

Role of dacarbazine in the treatment of recurrent mullerian adenosarcoma with sarcomatous overgrowth: Our experience.

Gardella B, Bogliolo S, Dominoni M, Zanellini F, Cassani C, Musacchi V, Bertone A, Babilonti L, Spinillo A.

J Obstet Gynaecol. 2016 Oct;36(7):886-887. Epub 2016 May 3. No abstract available.

PMID:
27139896
12.

Primary extra-uterine and extra-ovarian mullerian adenosarcoma: case report and literature review.

Mandato VD, Torricelli F, Mastrofilippo V, Valli R, Aguzzoli L, La Sala GB.

BMC Cancer. 2018 Feb 5;18(1):134. doi: 10.1186/s12885-018-4037-y. Review.

13.

Surgical conservation of both ovaries in an adolescent with uterine müllerian adenosarcoma: a case report.

Ozmen B, Uzum N, Unlu C, Ortac F, Ataoglu O.

J Minim Invasive Gynecol. 2007 May-Jun;14(3):375-8.

PMID:
17478375
14.

[Mullerian adenosarcoma of the uterus: A clinicopathologic analysis of 9 cases].

Han XY, Xiang Y, Guo LN, Sheng K, Wan XR, Huang HF, Pan LY.

Zhonghua Zhong Liu Za Zhi. 2010 Jan;32(1):44-7. Chinese.

PMID:
20211067
15.

Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma.

Nasioudis D, Chapman-Davis E, Frey M, Holcomb K.

J Gynecol Oncol. 2017 Jul;28(4):e46. doi: 10.3802/jgo.2017.28.e46.

16.

Diagnosis and management of Müllerian adenosarcoma of the uterine cervix.

Chin PS, Chia YN, Lim YK, Yam KL.

Int J Gynaecol Obstet. 2013 Jun;121(3):229-32. doi: 10.1016/j.ijgo.2012.12.015. Epub 2013 Mar 13.

PMID:
23490428
17.

Uterine adenosarcomas: a dual-institution update on staging, prognosis and survival.

Bernard B, Clarke BA, Malowany JI, McAlpine J, Lee CH, Atenafu EG, Ferguson S, Mackay H.

Gynecol Oncol. 2013 Dec;131(3):634-9. doi: 10.1016/j.ygyno.2013.09.011. Epub 2013 Oct 14.

PMID:
24135678
18.

Clinical management of uterine cervical mullerian adenosarcoma: A clinicopathological study of six cases and review of the literature.

Togami S, Kawamura T, Fukuda M, Yanazume S, Kamio M, Kobayashi H.

Taiwan J Obstet Gynecol. 2018 Aug;57(4):479-482. doi: 10.1016/j.tjog.2018.04.032.

19.

Ovarian conservation in a woman of reproductive age with müllerian adenosarcoma.

Michener CM, Simon NL.

Gynecol Oncol. 2001 Nov;83(2):424-7.

PMID:
11606111
20.

The diagnosis and treatment of Mullerian adenosarcoma of the uterus.

Shi Y, Liu Z, Peng Z, Liu H, Yang K, Yao X.

Aust N Z J Obstet Gynaecol. 2008 Dec;48(6):596-600. doi: 10.1111/j.1479-828X.2008.00914.x.

PMID:
19133051

Supplemental Content

Support Center